Spinal Cord Stimulation May Reduce Neuropathic Pain

Share this content:
Spinal Cord Stimulation May Reduce Neuropathic Pain
Spinal Cord Stimulation May Reduce Neuropathic Pain

MONDAY, Nov. 20, 2017 (HealthDay News) -- Spinal cord stimulation (SCS) effectively reduces chronic pain symptoms in individuals with painful diabetic polyneuropathy (PDPN), according to a study published online Nov. 6 in Diabetes Care.

Maarten van Beek, from Maastricht University Medical Center in the Netherlands, and colleagues performed a prospective multicenter study to examine the long-term effect of SCS on pain ratings, treatment success and failure, and complications in 48 patients with PDPN.

The researchers found that after five years, 55 percent of patients had experienced treatment success and 80 percent of patients with a permanent implant still used their SCS device. The median duration of SCS treatment was 60 months. Higher Michigan Diabetic Neuropathy Score was associated with treatment failure during the five-year follow-up (hazard ratio, 3.9).

"SCS is successful in reducing chronic pain symptoms in the lower extremities of patients with PDPN up to five years after initiation of treatment," the authors write.

The study was funded by Medtronic.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

First drug to be approved for rare autoimmune disease that leads to vasculitis

Findings Support Individualized Glycemic Control in T2DM

Findings Support Individualized Glycemic Control in T2DM

Approach saved $13,547/patient vs uniform intensive control, with lower medication costs

Atherosclerosis ID'd in Many Without CV Risk Factors

Atherosclerosis ID'd in Many Without CV Risk Factors

LDL-C independently associated with the presence and extent of atherosclerosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »